Table 3. Correlation of GLUT-1 and clinical factors in pancreatic cancer.
| Variable | No. of studies | OR (95% CI) | p | Heterogeneity | Model used | |
|---|---|---|---|---|---|---|
| I2 (%) | Ph | |||||
| Tumor size (>2 cm vs ≤2 cm) | 5 | 2.16(1.2-3.9) | 0.01 | 41.2 | 0.147 | Fixed |
| Lymph node metastasis (yes vs no) | 5 | 3.29(1.38-7.84) | 0.007 | 64.4 | 0.024 | Random |
| Histological grade (poor vs moderate/well) | 4 | 1.95(0.74-5.16) | 0.18 | 61.8 | 0.049 | Random |
| Age (>62 vs ≤62) | 4 | 0.95(0.58-1.57) | 0.855 | 0 | 0.57 | Fixed |
| Gender (male vs female) | 4 | 1(0.66-1.82) | 0.712 | 0 | 0.947 | Fixed |
| TNM stage (III + IV vs I + II) | 3 | 1.69(0.44-6.52) | 0.449 | 71.5 | 0.03 | Random |
| Vascular invasion (yes vs no) | 3 | 0.58(0.27-1.22) | 0.149 | 0 | 0.437 | Fixed |